Compare $ABVC vs $SHPH | Chartloom

Compare

$ABVC vs $SHPH

ABVC Biopharma Inc · Shuttle Pharmaceuticals Holdings Inc

ABVC

ABVC Biopharma Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Compare $ABVC vs $SHPH

Comparing ABVC Biopharma Inc and Shuttle Pharmaceuticals Holdings Inc

ABVCABVC Biopharma Inc

SHPHShuttle Pharmaceuticals Holdings Inc

ABVCABVC Biopharma Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-54.3%

52W performance

-69.1%

FCF yield

-10.4%

SHPHShuttle Pharmaceuticals Holdings Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.6%

52W performance

-87.9%

FCF yield

-283.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABVC

SHPH

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

ABVC$26M

SHPH$3M

Enterprise Value

ABVC$27M

SHPH$3M

Price

ABVC$1.00

SHPH$5.33

P/E Ratio

ABVCN/A

SHPHN/A

P/S Ratio

ABVC39.44x

SHPH0.00x

EV/Sales

ABVC40.47x

SHPH0.00x

EV/EBITDA

ABVC0.00x

SHPH0.00x

P/B Ratio

ABVC3.06x

SHPH5.94x

P/FCF Ratio

ABVCN/A

SHPHN/A

EV/FCF

ABVC-9.95x

SHPH-0.34x

PEG Ratio

ABVCN/A

SHPHN/A

Forward P/E (NTM)

ABVCN/A

SHPHN/A

Forward P/S (NTM)

ABVCN/A

SHPHN/A

Revenue (TTM)

ABVC$0

SHPH$0

Revenue Growth (YoY)

ABVC-100.0%

SHPHN/A

Forward Rev Growth

ABVC0.0%

SHPH0.0%

Gross Margin (TTM)

ABVC0.3%

SHPH0.0%

Operating Margin (TTM)

ABVC0.0%

SHPH0.0%

EBITDA Margin (TTM)

ABVC0.0%

SHPH0.0%

Net Margin (TTM)

ABVC0.0%

SHPH0.0%

FCF Margin (TTM)

ABVCN/A

SHPHN/A

Net Income (TTM)

ABVC$-8M

SHPH$-10M

FCF (TTM)

ABVC$-3M

SHPH$-10M

EPS (TTM)

ABVC-$0.30

SHPH-$10.11

ROE (TTM)

ABVC-7147.0%

SHPH-40833.0%

ROA (TTM)

ABVC-3883.0%

SHPH-13815.0%

ROIC (TTM)

ABVC-6509.0%

SHPH-37757.0%

Cash

ABVC$32K

SHPH$90K

Debt

ABVC$859K

SHPH$0

Net Cash/Debt

ABVC$-827K

SHPH$90K

Current Ratio (TTM)

ABVC0.07x

SHPH0.30x

Quick Ratio (TTM)

ABVC0.05x

SHPH0.13x

Debt/Equity (TTM)

ABVC0.08x

SHPH1.23x

Debt/Assets (TTM)

ABVC0.0%

SHPH0.0%

Interest Coverage (TTM)

ABVCN/A

SHPHN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

SHPH0.00x

Beta

ABVC0.50

SHPH1.13

52W Performance

ABVC-69.1%

SHPH-87.9%

YTD Performance

ABVC-54.3%

SHPH-70.6%

% from 52W High

ABVC-70.0%

SHPH-90.5%

% from 52W Low

ABVC40.8%

SHPH106.9%

Asset Turnover (TTM)

ABVC0.06x

SHPH0.00x

FCF Yield (TTM)

ABVC-10.4%

SHPH-283.7%

Earnings Yield (TTM)

ABVC-30.4%

SHPH-300.8%

Dividend Yield (TTM)

ABVCN/A

SHPHN/A

Rule of 40

ABVC-100.0

SHPH0.0

EV/GP/RG

ABVCN/A

SHPHN/A

Ticker research

View ABVC research View SHPH research

Metric	ABVC ABVC Biopharma Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$26M	$3M
Enterprise Value	$27M	$3M
Price	$1.00	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	0.00x
EV/Sales	40.47x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-10M
FCF (TTM)	$-3M	$-10M
EPS (TTM)	-$0.30	-$10.11
ROE (TTM)	-7147.0%	-40833.0%
ROA (TTM)	-3883.0%	-13815.0%
ROIC (TTM)	-6509.0%	-37757.0%
Financial Health
Cash	$32K	$90K
Debt	$859K	$0
Net Cash/Debt	$-827K	$90K
Current Ratio (TTM)	0.07x	0.30x
Quick Ratio (TTM)	0.05x	0.13x
Debt/Equity (TTM)	0.08x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.13
52W Performance	-69.1%	-87.9%
YTD Performance	-54.3%	-70.6%
% from 52W High	-70.0%	-90.5%
% from 52W Low	40.8%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-10.4%	-283.7%
Earnings Yield (TTM)	-30.4%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View SHPH research

Valuation

P/S Ratio

SHPH

0.00x

ABVC

39.44x

EV/FCF

ABVC

-9.95x

SHPH

-0.34x

Growth & revenue

Revenue Growth TTM

ABVC

-100.0%

Forward Revenue Growth

ABVC

0.0%

SHPH

0.0%

Profitability & performance

Gross Margin

ABVC

0.3%

SHPH

0.0%

ROE

ABVC

-7147.0%

SHPH

-40833.0%

FCF Yield %

ABVC

-10.4%

SHPH

-283.7%

52-Week Performance

ABVC

-69.1%

SHPH

-87.9%

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

ABVC$26M

SHPH$3M

Enterprise Value

ABVC$27M

SHPH$3M

Price

ABVC$1.00

SHPH$5.33

P/E Ratio

ABVCN/A

SHPHN/A

P/S Ratio

ABVC39.44x

SHPH0.00x

EV/Sales

ABVC40.47x

SHPH0.00x

EV/EBITDA

ABVC0.00x

SHPH0.00x

P/B Ratio

ABVC3.06x

SHPH5.94x

P/FCF Ratio

ABVCN/A

SHPHN/A

EV/FCF

ABVC-9.95x

SHPH-0.34x

PEG Ratio

ABVCN/A

SHPHN/A

Forward P/E (NTM)

ABVCN/A

SHPHN/A

Forward P/S (NTM)

ABVCN/A

SHPHN/A

Revenue (TTM)

ABVC$0

SHPH$0

Revenue Growth (YoY)

ABVC-100.0%

SHPHN/A

Forward Rev Growth

ABVC0.0%

SHPH0.0%

Gross Margin (TTM)

ABVC0.3%

SHPH0.0%

Operating Margin (TTM)

ABVC0.0%

SHPH0.0%

EBITDA Margin (TTM)

ABVC0.0%

SHPH0.0%

Net Margin (TTM)

ABVC0.0%

SHPH0.0%

FCF Margin (TTM)

ABVCN/A

SHPHN/A

Net Income (TTM)

ABVC$-8M

SHPH$-10M

FCF (TTM)

ABVC$-3M

SHPH$-10M

EPS (TTM)

ABVC-$0.30

SHPH-$10.11

ROE (TTM)

ABVC-7147.0%

SHPH-40833.0%

ROA (TTM)

ABVC-3883.0%

SHPH-13815.0%

ROIC (TTM)

ABVC-6509.0%

SHPH-37757.0%

Cash

ABVC$32K

SHPH$90K

Debt

ABVC$859K

SHPH$0

Net Cash/Debt

ABVC$-827K

SHPH$90K

Current Ratio (TTM)

ABVC0.07x

SHPH0.30x

Quick Ratio (TTM)

ABVC0.05x

SHPH0.13x

Debt/Equity (TTM)

ABVC0.08x

SHPH1.23x

Debt/Assets (TTM)

ABVC0.0%

SHPH0.0%

Interest Coverage (TTM)

ABVCN/A

SHPHN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

SHPH0.00x

Beta

ABVC0.50

SHPH1.13

52W Performance

ABVC-69.1%

SHPH-87.9%

YTD Performance

ABVC-54.3%

SHPH-70.6%

% from 52W High

ABVC-70.0%

SHPH-90.5%

% from 52W Low

ABVC40.8%

SHPH106.9%

Asset Turnover (TTM)

ABVC0.06x

SHPH0.00x

FCF Yield (TTM)

ABVC-10.4%

SHPH-283.7%

Earnings Yield (TTM)

ABVC-30.4%

SHPH-300.8%

Dividend Yield (TTM)

ABVCN/A

SHPHN/A

Rule of 40

ABVC-100.0

SHPH0.0

EV/GP/RG

ABVCN/A

SHPHN/A

Ticker research

View ABVC research View SHPH research

Metric	ABVC ABVC Biopharma Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$26M	$3M
Enterprise Value	$27M	$3M
Price	$1.00	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	0.00x
EV/Sales	40.47x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-10M
FCF (TTM)	$-3M	$-10M
EPS (TTM)	-$0.30	-$10.11
ROE (TTM)	-7147.0%	-40833.0%
ROA (TTM)	-3883.0%	-13815.0%
ROIC (TTM)	-6509.0%	-37757.0%
Financial Health
Cash	$32K	$90K
Debt	$859K	$0
Net Cash/Debt	$-827K	$90K
Current Ratio (TTM)	0.07x	0.30x
Quick Ratio (TTM)	0.05x	0.13x
Debt/Equity (TTM)	0.08x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.13
52W Performance	-69.1%	-87.9%
YTD Performance	-54.3%	-70.6%
% from 52W High	-70.0%	-90.5%
% from 52W Low	40.8%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-10.4%	-283.7%
Earnings Yield (TTM)	-30.4%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View SHPH research